Rapid, noninvasive tool tracks neurons and biomolecules activated in the brain by psychedelic drugs

Researchers at the University of California, Davis have developed a rapid, noninvasive tool to track the neurons and biomolecules activated in the brain by psychedelic drugs.

Kura’s AML drug passes key study in advanced patients, plans next steps with FDA and newly diagnosed studies

The race is on between Kura Oncology and Syndax Pharmaceuticals. On Wednesday, Kura and its partner Kyowa Kirin announced that their targeted treatment ziftomenib succeeded

February 7, 2025

Quidelortho sees highest filings and grants during October in Q4 2023

Share this article Quidelortho has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q4 2023 The European Patent Office(EPO) Patent

February 27, 2024

FDA says Ozempic, Wegovy shortage is over

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.